Last reviewed · How we verify
Opioids
At a glance
| Generic name | Opioids |
|---|---|
| Also known as | Analgesics, Narcotics, Pharmacologic pain management, Opioid, Opioid prescribed to the patient on routine basis |
| Sponsor | Marc M. Perreault |
| Modality | Small molecule |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives (NA)
- Opioid, HIV and Immune System (PHASE4)
- Development of an Intervention to Enhance Cancer Pain Management (NA)
- Facilitating Opioid Care Connections (NA)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System (NA)
- Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Opioids CI brief — competitive landscape report
- Opioids updates RSS · CI watch RSS
- Marc M. Perreault portfolio CI